Skip to content

Descriptive Assessment of Practice in Anaesthesia : Lidocaine 1% Adrenaline Under in Axillary Block Realization

Descriptive Assessment of Practice in Anaesthesia : Lidocaine 1% Adrenaline Under in Axillary Block Realization

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03290404
Acronym
fLACON
Enrollment
292
Registered
2017-09-21
Start date
2017-11-13
Completion date
2018-03-19
Last updated
2018-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Axillary Block

Keywords

Axillary Block, LidocaÏne 1% adrenaliné

Brief summary

Axillary block is the good anesthetic technique for upper limb surgery without exceeding a certain total dose injected of Local Anesthetic (AL). The maximal recommended dose of Lidocaine adrenaline in the upper limb is 500 mg. The use of ultrasound helps guiding the locoregional anesthesia, and allows to decrease the AL concentration, thus decreasing the risks. No previous study estimated a concentration of lidocaine lower than 1,5 % to realize upper limb surgery by axillary block. The literature overestimating probably the rate of failure of the locoregional anesthesia under ultrasound-guidance, we suggest to estimate the rate of failure of the axillary block ultrasound-guided with the lidocaine 1 % adrenaline for realizing upper limb surgery in standard practice.

Interventions

None listed

Sponsors

University Hospital, Brest
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients operated for the upper limb under block axillaire * Adult * non-opposition

Exclusion criteria

* medical advice to realize axillary block * medical advice to local anaesthetic * Allergy * Pregnant * ASA 3 or more

Design outcomes

Primary

MeasureTime frameDescription
Resort to an anesthesia for help in case of ineffectiveness of the blockDay 1Yes or no Yes or No

Secondary

MeasureTime frameDescription
Block depthDay 1Bromage score

Other

MeasureTime frameDescription
Time of BlockDay 1Minutes
Total dose of Lidocaïne adrenaline usedDay 1mg
Patient satisfactionDay 1questionnaire score

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026